Guidance for Individuals Vaccinated Outside the United States
As travel resumes and more individuals come to Wisconsin for school or work, it is increasingly likely that these individuals may already be vaccinated and want to know if they are appropriately vaccinated according to standards in Wisconsin.
The Wisconsin Department of Health Services (DHS) offers the following guidance to assist vaccinators in taking the proper actions with individuals who have been vaccinated outside of the United States. Official guidance from the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) is also included in the chart and scenarios listed below.
|
|
The individual already received a vaccine that is FDA-authorized for emergency use vaccine AND/OR
a WHO-listed for emergency use vaccine
|
The individual received a complete or partial series
|
Vaccinator action
|
|
1.
|
Received FDA-authorized vaccine that is
|
WHO-listed vaccine
|
Complete
|
No further vaccine doses needed
|
|
2.
|
Received FDA-authorized vaccine that is
|
WHO-listed vaccine
|
Partial
|
Complete series with correct vaccine product
|
|
3.
|
Received non FDA-authorized vaccine that is
|
WHO-listed vaccine
|
Complete
|
No further vaccine doses needed
|
|
4.
|
Received non FDA-authorized vaccine that is
|
WHO-listed vaccine
|
Partial
|
Offer a complete FDA-authorized vaccine series
|
|
5.
|
Received non FDA-authorized vaccine that is
|
Not a WHO-listed vaccine
|
Complete or partial
|
Offer FDA-authorized vaccine series
|
Scenario 1: If an individual completed a series for an FDA-authorized and WHO-listed vaccine series then no further vaccine doses are needed.
Scenario 2: If an individual received part of an FDA-authorized and WHO-listed vaccine series, then you should complete series with correct vaccine product.
Scenario 3: If an individual completed a non FDA-Authorized vaccine series that is a WHO-listed vaccine series, then no further vaccine doses are needed.
Scenario 4: If an individual received a partial series of a non FDA-authorized, but WHO-listed vaccine, then offer a complete FDA-authorized vaccines series.
Scenario 5: If an individual received either a complete or partial series of a non FDA-authorized and Non-WHO listed vaccine, then offer an FDA-authorized vaccine series.
As of June 9, 2021, FDA has authorized the following COVID-19 vaccines for emergency use:
- Pfizer-BioNTech COVID-19 vaccine
- Moderna COVID-19 vaccine
- Janssen (Johnson & Johnson) COVID-19 vaccine
As of June 9, 2021, WHO has listed the following COVID-19 vaccines for emergency use:
- Pfizer-BioNTech COVID-19 vaccines (Also known as COMIRNATY or Tozinameran)
- AstraZeneca-Oxford COVID-19 vaccines (Also known as Covishield or Vaxzevria)
- Janssen (Johnson & Johnson) COVID-19 vaccine
- Moderna COVID-19 vaccine
- Sinopharm COVID-19 vaccine
Please refer to the Status of COVID-19 Vaccine within WHO EUL/PQ evaluation process for the most up-to-date information:
https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_23April2021.pdf?_sm_au_=inVZqjc6fZKrcv0qBLQtvK7BJGKjp
CDC’s complete guidance can be found in the Interim Clinical Considerations for Use of COVID-19 Vaccines | CDC, which states:
People who were vaccinated outside the United States with a COVID-19 vaccine that is FDA-authorized for emergency use and have received all the recommended doses do not need any additional doses. People who received the first dose of a COVID-19 vaccine that is FDA- authorized for emergency use that requires two doses do not need to restart the vaccine series in the United States but should receive the second dose as close to the recommended time as possible.
Some people may have received a COVID-19 vaccine that is not currently authorized in the United States. No data are available on the safety or efficacy of receiving a COVID-19 vaccine currently authorized in the United States after receipt of a COVID-19 vaccine that is non-FDA-authorized for emergency use. However, in some circumstances people who received a COVID-19 vaccine not currently authorized in the United States may be offered revaccination with an FDA-authorized vaccine:
- COVID-19 vaccines not authorized by FDA but listed for emergency use by the World Health Organization (WHO)2
- People who have not received all the recommended doses of a COVID-19 vaccine listed for emergency use by WHO may be offered a complete FDA-authorized COVID-19 vaccine series.
- COVID-19 vaccines neither authorized by FDA nor listed for emergency use by WHO
- People who received all or some of the recommended doses of a COVID-19 vaccine that is neither authorized by FDA nor listed for emergency use by WHO may be offered a complete FDA-authorized COVID-19 vaccine series.
The minimum interval between the last dose of a non-FDA authorized vaccine or a WHO-listed vaccine and an FDA-authorized COVID-19 vaccine is 28 days. Only people who have received all recommended doses of an FDA or WHO-emergency authorized COVID-19 vaccine are considered fully vaccinated for the purpose of public health guidance.3
|
